Table 3. Evolution of Endometrial Variables Pre and Post Treatment eMSCs |
|||
Variables |
PreSCs |
Post SCs |
p value |
Endometrial Thickness |
5.25±1.24 |
9.93 ± 0.77 |
0.000* |
Endometrial Flow Cytometry |
|
|
|
Li/PC |
|
|
|
Normal |
13/29 (44.8%) |
20/29 (69%) |
0.167† |
Abnormal |
16/29 (55.2%) |
9/29 (31%) |
|
LT |
|
|
|
Normal |
15/29 (51.7%) |
26/29 (89.7%) |
0.013† |
Abnormal |
14/29 (48.3%) |
3/29 (10.3%) |
|
LB |
|
|
|
Normal |
8/29 (27.6%) |
18/29 (62.1%) |
0.002† |
Abnormal |
21/29 (72.4%) |
11/29 (37.9%) |
|
NK |
|
|
|
Normal |
14/29 (48.3%) |
23/29 (79.3%) |
0.049† |
Abnormal |
15/29 (51.7%) |
6/29 (20.7%) |
|
CD4 |
|
|
|
Normal |
14/29 (48.3%) |
21/29 (72.4%) |
0.118† |
Abnormal |
15/29 (51.7%) |
8/29 (27.6%) |
|
CD8 |
|
|
|
Normal |
13/29 (44.8%) |
25/29 (86.2%) |
0.000† |
Abnormal |
16/29 (55.2%) |
4/29 (13.8%) |
|
CD4/CD8 |
|
|
|
Normal |
13/29 (44.8%) |
28/29 (96.6%) |
0.000† |
Abnormal |
16/29 (55.2%) |
1/29 (3.4%) |
|
Endometrial Histopathology |
|
|
|
Normal |
6/29 (20.7%) |
17/29 (58.6%) |
0.007† |
Abnormal |
23/29 (79.3%) |
12/29 (41.4%) |
|
| * T-test paired samples,† McNemar Test. | |||